Publications by authors named "Justin A Ezekowitz"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,962

Total Likes

553

Extended Reach

3,185,635

Social Features

217
F
Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
Robert J Mentz, Jyotsna Garg, Frank W Rockhold, Javed Butler, Carmine G De Pasquale, Justin A Ezekowitz, Gregory D Lewis, Eileen O'Meara, Piotr Ponikowski, Richard W Troughton

September 2023

Videos about Article: user user

2 5 3 210 2 125

View All Article and Social Media Activity
R
Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial.
Ilan Goldenberg, Wojciech Zareba, Justin A Ezekowitz, Christine Albert, Jeffrey D Alexis

Am Heart J· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR.
Faiez Zannad, Yogesh N V Reddy, Irina Barash, Kevin J Anstrom, Marc P Bonaca, Justin A Ezekowitz

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network Meta-Analysis of Quality of Life in Heart Failure With Reduced Ejection Fraction.
Robert Margaryan, Nariman Sepehrvand, Wouter Ouwerkerk, Jasper Tromp, Ricky D Turgeon, Justin A Ezekowitz

Circ Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic region variation in patient characteristics, clinical outcomes and treatment of HFrEF in the VICTORIA trial.
Cynthia M Westerhout, Wendimagegn Alemayehu, Alain Cohen-Solal, Carolyn S P Lam, Justin A Ezekowitz

ESC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FID.
Gregory D Lewis, Anna Giczewska, Robert J Mentz, Javed Butler, Justin A Ezekowitz

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial.
Caio A M Tavares, Luciano C P Azevedo, Patrícia O Guimarães, Álvaro Rea-Neto, Paula G David-João, Justin A Ezekowitz

JACC Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).: Volume 41, Issue 10, October 2025, Pages 1857-74.
Sean Virani, Shelley Zieroth, Natasha Aleksova, Kim Anderson, Brian Clarke, Justin A Ezekowitz

Can J Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy.
Palak Shah, Yinggan Zheng, Burkert Pieske, Vojtech Melenovsky, Carolyn S P Lam, Justin A Ezekowitz

Circ Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).
Sean Virani, Shelley Zieroth, Natasha Aleksova, Kim Anderson, Brian Clarke, Justin A Ezekowitz

Can J Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperkalemia-Related Heart Failure Therapy Discontinuation and the Association With Outcomes in Patients With Heart Failure.
Aanchel Gupta, Sunjidatul Islam, Douglas C Dover, Padma Kaul, Finlay McAlister, Justin A Ezekowitz

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet and Clinical Outcomes in a Heart Failure Population.
Philip Joseph, Mahshid Dehghan, Justin A Ezekowitz, Victoria Miller, Fernando Lanas

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline-Directed Medical Therapy Use in the STRONG-HF Trial.
Xiang Zhang, Beth Davison, Marianna Adamo, Mattia Arrigo, Jan Biegus, Justin A Ezekowitz

Circ Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic Variation and Human Development Index in Heart Failure With Reduced Ejection Fraction: Insights From VICTORIA.
Alain Cohen-Solal, Wendimagegn Alemayehu, Carolyn S P Lam, Hiroyuki Tsutsui, Jian Zhang, Justin A Ezekowitz

JACC Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
Faiez Zannad, Christopher M O'Connor, Javed Butler, Ciaran J McMullan, Kevin J Anstrom, Justin A Ezekowitz

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Javed Butler, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, Marc P Bonaca, Justin A Ezekowitz

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Robert J Mentz, Javed Butler, Ciaran J McMullan, Daniel M Wojdyla, Kevin J Anstrom, Justin A Ezekowitz

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial.
Javed Butler, Francesco Fioretti, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, Justin A Ezekowitz

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification.
Christopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, Stefano Corda, Ciaran J McMULLAN, Justin A Ezekowitz

J Card Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Device Therapy in Patients with Heart Failure: Is Medication Use Optimized and Are We Targeting Those Patients Most Likely to Benefit?
Robert Wannamaker, Roopinder K Sandhu, Justin A Ezekowitz, Sheri L Koshman, Derek S Chew

CJC Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.
Vijay Chopra, Muhammad Shahzeb Khan, Magdy Abdelhamid, William T Abraham, Offer Amir, Justin A Ezekowitz

Heart Lung Circ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study.
Andreas P Kalogeropoulos, Ishaque Hameed, Stefan D Anker, Antoni Bayes-Genis, Michael Böhm, Justin A Ezekowitz

Eur J Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting ICD Therapy for Primary Prevention: The CONTEMP-ICD Trial.
Ilan Goldenberg, Justin A Ezekowitz, Javed Butler

JACC Heart Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study.
Vanessa Blumer, James L Januzzi, Yuxi Liu, Javed Butler, Justin A Ezekowitz

JACC Heart Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Pathway Inhibition in Patients with Atherosclerosis with or without Heart Failure: Insights from the XATOA Registry.
Pishoy Gouda, Justin A Ezekowitz, Alain Gay, Kai Vogtländer, Victor Aboyans

CJC Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Treatment Effects in the Reduction of Dietary Sodium to Less Than 100 mmol in Heart Failure (SODIUM-HF): A Secondary Post Hoc Analysis.
Fernando G Zampieri, Sarah Rathwell, Finlay A McAlister, Heather Ross, Jorge Escobedo, Justin A Ezekowitz

J Card Fail· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis